Anti-tumor APIs are a class of drugs that inhibit or kill tumor cells in the body, which are classified as chemotherapy drugs, targeted therapy drugs, immunotherapy drugs, and hormone therapy drugs according to the mode of action. Chemotherapy API works by interfering with the cell division process, thereby inhibiting the growth of cancer cells. Targeted APIs are designed to attack specific molecules or genes involved in cancer growth, minimizing damage to healthy cells. Immunotherapy APIs stimulate the body's immune system to recognize and destroy cancer cells. Hormone therapy APIs are used to treat hormone-dependent cancers, such as breast or prostate cancer, by blocking hormones that promote cancer cell growth.

Protheragen has an advanced API production platform and is committed to providing a full range of anti-tumor APIs and customized services according to customer needs.